Coronavirus Update - 07th August 2020

We would like to take this opportunity to thank our clients and staff for their continued support over this period of restricted movement. 

We remain open for business as usual and have started welcoming limited numbers of visitors to site

We fully comply with all government guidance on minimising the risks of COVID-19 and have published our risk assessment here

Latest hybrid LC-MS techniques to resolve your peptide analytical questions.

Michael Blackburn, Bioanalytical Scientist (Method Development), Bioanalytical Servicest, here at Arcinova, discusses using MSIA with mass spectrometry to analyse therapeutic peptides. A range of different techniques are discussed in relation to the analysis of therapeutic peptides, citing insulin as an example. 

Click to view webinar